Feline hyperthyroidism is the most common endocrine disorder in middle-aged to older cats, and one of the most frequently diagnosed conditions in feline primary care. It is also one of the conditions where the follow-up period immediately after diagnosis and treatment initiation is most clinically critical — not because the treatment is dangerous in itself, but because of what the treatment reveals. Hyperthyroidism increases renal blood flow and glomerular filtration rate, effectively masking concurrent chronic kidney disease. When thyroid hormone levels are reduced by treatment, renal function may deteriorate significantly — sometimes within the first few weeks. The 2016 AAFP Guidelines for the Management of Feline Hyperthyroidism recommend that kidney values and total T4 be monitored every 2–4 weeks for up to 3 months following initiation of therapy. This window is not optional.
Why post-treatment follow-up is the highest-risk period for hyperthyroid cats
The unmasking of CKD after treatment is the most clinically significant risk in managing feline hyperthyroidism. Research has shown that 10–20% of hyperthyroid cats have concurrent hypertension, and a further 20–25% of cats who are normotensive at diagnosis develop hypertension after treatment. Both of these changes — worsening renal function and new hypertension — can develop within 2–4 weeks of starting methimazole or following radioactive iodine therapy or thyroidectomy.
The methimazole side effect profile adds additional follow-up requirements. Facial excoriation, vomiting, lethargy, anorexia, liver enzyme elevation, and haematological changes (thrombocytopenia, neutropenia) are documented adverse effects that typically occur within the first 4–8 weeks of treatment. Owners need to be explicitly briefed on what to watch for and, critically, need to be asked about these signs at follow-up — because many owners attribute early vomiting or reduced appetite to the original disease rather than the medication.
For cats managed with the prescription low-iodine diet (Hill’s y/d), the follow-up requirement is lifelong dietary compliance. If even one other food source is introduced — treats, hunting, table scraps — the diet fails and hyperthyroidism returns. A follow-up call that probes dietary compliance is a clinical necessity, not a nicety.
For radioactive iodine — the curative option with a success rate greater than 95% — the AAFP guidelines still recommend monitoring at 2–4 weeks, 2–4 months, and then 4–6 monthly thereafter, with particular attention to post-treatment renal function.
The hyperthyroidism follow-up timeline
| Timepoint | What to check | Red flags |
|---|---|---|
| 2–4 weeks post-treatment | T4 level, kidney values (creatinine, BUN, SDMA), blood pressure, clinical signs improving, methimazole side effects, weight stabilising | Deteriorating kidney values — may warrant reassessment of treatment dose or target T4; new hypertension; facial lesions, vomiting or anorexia with methimazole |
| 6–8 weeks | T4 in target range, renal values stable, blood pressure controlled, owner comfort with medication administration | T4 above target range — dose adjustment needed; owner struggling to medicate, considering stopping |
| 3 months | T4, full biochemistry, blood pressure — establish stable monitoring baseline | Persistent azotaemia requiring modification of treatment strategy; methimazole dose inadequate or excessive |
| Every 4–6 months (stable patients) | T4, biochemistry, urinalysis, blood pressure — ongoing stable monitoring for medically managed cats | Any deterioration in renal function, recurrence of hyperthyroid signs (weight loss, restlessness, polyphagia), hypertension |
What to ask owners during hyperthyroidism follow-up
- Has [cat name]‘s weight stabilised, or is she continuing to lose weight?
- Is her appetite still increased, or has it begun to normalise?
- Has her activity level and restlessness reduced?
- Are you giving the methimazole consistently at the right times — and is she taking it without difficulty?
- Have you noticed any vomiting, reduced appetite, or lethargy since starting the medication?
- Has she been scratching at her face or developing any skin lesions around her face or neck?
- Is she drinking and urinating at a normal amount — or more or less than before?
- Is she still on the prescription diet only — no treats, no other food sources?
- Have you had her blood pressure checked since starting treatment?
- Do you have your 4-week recheck appointment booked?
Common hyperthyroidism follow-up mistakes clinics make
Not warning owners about CKD unmasking. Owners who are told “the treatment is working” and then see their cat deteriorating 3–4 weeks later are not prepared for this possibility. An explicit conversation at discharge — and a follow-up call at 2–4 weeks that specifically asks about changes in thirst, urination, and energy — prepares the owner and catches the renal deterioration early enough to adjust treatment strategy.
Missing the blood pressure check window. Given that 20–25% of normotensive hyperthyroid cats develop hypertension after treatment, blood pressure monitoring in the first 4–8 weeks post-treatment is essential. Hypertension that develops post-treatment without being detected can cause ocular damage (retinal detachment) and neurological signs before the next scheduled recheck.
Not probing methimazole compliance. Many owners find twice-daily medication in a resistant cat extremely difficult. Rather than telling the clinic, they skip doses, reduce frequency, or stop entirely. A follow-up call that directly asks — “has she been taking it without too much trouble?” — opens the door to a practical solution (transdermal formulation, pill pockets, dosing technique review) before non-compliance becomes treatment failure.
How to automate hyperthyroidism follow-up without adding to your team’s workload
Nidana Loop schedules a 2-week check call post-treatment initiation and a 6–8 week call automatically from the discharge note. The 2-week call specifically asks about methimazole side effects and any changes in thirst, urination or energy that could indicate CKD unmasking. The 6–8 week call confirms the blood monitoring recheck is booked. Stable patients on long-term methimazole can receive regular touchpoints every 4–6 months.
See how Loop handles hyperthyroidism follow-up calls → Book a 20-minute demo
Related: Chronic kidney disease follow-up in cats · Diabetes mellitus follow-up · Congestive heart failure follow-up